Emergent Biosolutions (ER4) Q2 2024 Earnings Report
DE:ER4 Q2 2024 EPS Results
- Actual EPS
- -EUR 2.07
- Consensus EPS
- -EUR 1.01
- Beat/Miss
- Missed by -EUR 1.06
- One Year Ago EPS
- -EUR 0.95
DE:ER4 Q2 2024 Revenue Results
- Actual Revenue
- EUR 227.73M
- Expected Revenue
- EUR 169.88M
- Beat/Miss
- Beat by +EUR 57.85M
- YoY Revenue Growth
- -24.62%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- After Close
- Conference Call
- Tuesday, August 6, 2024
DE:ER4 Upcoming Earnings
Emergent Biosolutions's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:ER4 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ER4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.07- | -0.38 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.35-0.32 | 0.95 | -133.96% (-1.27) | |
| Aug 05, 2026 | 2026 (Q2) | -0.080.54 | 0.14 | 275.00% (+0.39) | |
| Apr 30, 2026 | 2026 (Q1) | -0.220.19 | 0.63 | -70.42% (-0.45) | |
| Feb 26, 2026 | 2025 (Q4) | 0.10-0.38 | 0.04 | -960.00% (-0.43) | |
| Oct 29, 2025 | 2025 (Q3) | -0.110.95 | 1.22 | -22.63% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.440.14 | -2.07 | 106.90% (+2.22) | |
| May 07, 2025 | 2025 (Q1) | 0.390.63 | 0.53 | 20.34% (+0.11) | |
| Mar 03, 2025 | 2024 (Q4) | -0.450.04 | -0.69 | 106.49% (+0.73) | |
| Nov 06, 2024 | 2024 (Q3) | 0.091.22 | -0.48 | 353.70% (+1.71) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
